Biotech IPOs stride along

VCJ Venture Biotech
Photo of lab worker with money and test tubes courtesy of Motortion/iStock/Getty Images.
Biotech IPOs have had a charmed year in the public markets. Expect more enchantment to follow. Through the third quarter, 45 biopharma companies have held offerings on U.S. exchanges, according to Silicon Valley Bank. The sector is on pace this ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.